The Swiss DolorClast is a low-energy Extracorporeal Shockwave Therapy (ESWT) device that draws on the latest medical technology to treat Plantar Fasciitis and Achilles Tendonopathy.
Extracorporeal Shockwave Therapy is a relatively new technology and The National Institute of Health and Clinical Excellence (NICE) recently issued guidance that it is a safe treatment option for foot and ankle injuries. ESWT is a beneficial alternative to invasive surgery and the Swiss DolorClast can be used to treat and manage symptoms.
The Swiss DolorClast works by passing low-energy radial shockwaves through the skin to the injured part of the body. Passing these shockwaves through the surface of the skin initiates an inflammation-like condition in the injured tissue that is being treated. This prompts the body to respond naturally by increasing blood circulation, the number of blood vessels and therefore metabolism in the injured tissue.
The UK now boasts an ever-expanding network of orthopaedic surgeons and physiotherapists that are using the Swiss DolorClast.